Roivant Sciences (ROIV) Total Current Liabilities (2021 - 2026)

Roivant Sciences' Total Current Liabilities history runs 6 years deep, the most recent figure standing at $281.2 million for Q1 2026.

• Quarterly Total Current Liabilities rose 88.24% year-over-year to $281.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $281.2 million (up 88.24% YoY) and the FY2026 annual result came in at $281.2 million, up 88.24% from the prior year.
• Total Current Liabilities was $281.2 million for Q1 2026 at Roivant Sciences, down from $469.1 million in the prior quarter.
• Across five years, Total Current Liabilities topped out at $556.2 million in Q3 2024 and bottomed at $877000.0 in Q4 2022.
• A 5-year average of $199.0 million and a median of $190.1 million in 2022 frame the typical range for Total Current Liabilities.
• Annual changes were most pronounced in 2022 — Total Current Liabilities tumbled 99.45% — and 2024, when it surged 38448.09%.
• Roivant Sciences' Total Current Liabilities stood at $877000.0 in 2022, then jumped by 35370.24% to $311.1 million in 2023, then advanced by 5.96% to $329.6 million in 2024, then jumped by 42.3% to $469.1 million in 2025, then plunged by 40.04% to $281.2 million in 2026.
• Business Quant data shows ROIV's Total Current Liabilities at $281.2 million in Q1 2026, $469.1 million in Q4 2025, and $133.9 million in Q3 2025.